Last reviewed: June 20, 2026

Last updated: June 20, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, the active ingredient in medications like Wegovy, works through a carefully structured dosing protocol that starts low and increases over time. Understanding how your dose progresses—and why that progression matters—helps you set realistic expectations and stay committed to your weight loss plan. PlexusDx offers compounded semaglutide injections from licensed 503A pharmacies, with transparent pricing that never increases as your dose does.

How Semaglutide Dosing Works: The Titration Schedule

Semaglutide dosing begins at the lowest effective amount and increases gradually over four to five months. The standard starting dose is 0.25 mg once weekly, which is purely designed to let your body adapt to the medication while your appetite-regulating systems begin to respond. Most patients experience minimal side effects at this entry level, making it an ideal foundation for long-term compliance.

Every four weeks, the dose typically increases by 0.25 mg increments: 0.5 mg in week 5, 0.75 mg in week 9, 1.0 mg in week 13, and finally 1.7 or 2.4 mg as maintenance doses for continued weight loss. This slow climb gives your gastrointestinal system time to adjust, reduces nausea, and allows your healthcare provider to monitor your response and tolerance. The entire titration phase is a deliberate strategy, not a limitation—it maximizes the chance you'll stick with treatment long-term.

Why Gradual Dose Increases Reduce Side Effects

Jumping to a high semaglutide dose immediately would overwhelm your system and likely trigger significant gastrointestinal discomfort, including nausea, vomiting, and constipation. By starting at 0.25 mg, your body's GLP-1 receptors—the molecular targets that control hunger and blood sugar—have time to become sensitized to the medication without shock. This measured approach is backed by clinical trials showing that slower titration schedules improve tolerability and treatment persistence.

Patients who follow the full titration protocol report fewer side effects and better quality of life during their weight loss journey compared to those attempting higher doses too quickly. Your body also becomes more efficient at using each dose level, meaning you achieve meaningful weight reduction even at lower amounts before advancing. PlexusDx providers support you through each titration step, ensuring you're comfortable and seeing measurable progress before moving forward.

Maintenance Doses and Long-Term Weight Management

Once you reach your target maintenance dose—typically 1.7 mg or 2.4 mg weekly—the goal shifts from titration to sustainability. The maintenance phase is where most of the weight loss stabilizes, and your body learns to function at a lower appetite set point controlled by the semaglutide's steady GLP-1 signaling. Clinical data shows that patients who stay on their maintenance dose continue losing weight gradually or maintain their losses over 12+ months of treatment.

Determining the right maintenance dose for you depends on your individual metabolism, baseline weight, previous weight loss attempts, and how your body responds to each titration step. Some patients find optimal results at 1.7 mg, while others need the full 2.4 mg for sustained weight loss. PlexusDx's approach to personalized medicine includes optional genetic testing via the Precision Peptide Genetic Test, which examines variants like GLP1R rs6923761 and MC4R rs17782313 to predict how your genetic makeup influences peptide-pathway responsiveness.

PlexusDx Compounded Semaglutide: Affordable Access at Every Dose Level

PlexusDx offers compounded semaglutide injections from licensed 503A pharmacies at a flat rate of $149 per month, regardless of your current dose level. This pricing structure means your cost stays the same whether you're in the 0.25 mg titration phase or maintaining on 2.4 mg—eliminating the financial burden that often derails patients as they advance through treatment. No membership fees, no insurance required, and every plan is HSA and FSA eligible, making weight loss therapy accessible to more people.

The compounding approach allows for precise dose customization and flexibility if your provider needs to adjust your regimen based on your response or tolerance. PlexusDx serves all 50 states with direct-to-patient access, meaning you don't navigate insurance delays or pharmacy limitations. If you want deeper insight into how your genetics may predict your semaglutide response, the optional Precision Peptide Genetic Test ($99 after your first month) maps 14 metabolic pathways and 49 peptides to guide truly personalized dosing decisions.

When to Expect Dose Adjustments or Changes

Your dose schedule isn't one-size-fits-all; some patients need slower titration due to side effects, while others may pause between increases if they're experiencing excellent weight loss at their current level. Your PlexusDx provider will assess your progress, tolerability, and weight loss velocity to decide whether you're ready to advance, hold steady, or even step back temporarily. Open communication about how you're feeling physically and mentally is crucial—this isn't a race, and the best dose is the one you can sustain.

Occasionally, patients may request a switch to oral semaglutide (available at PlexusDx for $249/month) if injections become inconvenient or if they want to explore a different delivery method. Some individuals find their optimal response at a lower-than-standard maintenance dose, which is perfectly valid and often results in fewer side effects with maintained weight loss. The flexibility built into PlexusDx's treatment model means your regimen can evolve as your needs and goals change throughout your journey.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is the starting dose of semaglutide for weight loss?

The standard starting dose is 0.25 mg injected subcutaneously once weekly. This minimal dose allows your body to adapt and begin activating GLP-1 receptors without overwhelming your system. PlexusDx providers follow evidence-based titration protocols to ensure you safely advance through each dose level over several months.

How long does it take to reach the full semaglutide dose?

The complete titration from 0.25 mg to a maintenance dose typically takes 16–20 weeks (roughly 4–5 months). Each dose increase occurs every four weeks, allowing adequate time for your body to adjust and for your provider to assess your response. This gradual progression is the most clinically sound approach for minimizing side effects and maximizing long-term adherence.

Can I skip a dose increase if I'm experiencing side effects?

Yes—pausing at your current dose for an extra week or two gives your body more time to adapt before advancing. Your PlexusDx provider can adjust your titration timeline based on your comfort level and tolerance. The goal is finding the dose that works for *you*, not forcing a predetermined schedule.

Will my PlexusDx cost increase as my dose goes up?

No. PlexusDx compounded semaglutide injections cost $149 per month flat, whether you're at 0.25 mg or 2.4 mg. Your dose may need to go up. Your price won't. This transparent pricing removes a major barrier to staying committed throughout your entire weight loss journey.

What is the Precision Peptide Genetic Test, and does it affect my dosing?

The Precision Peptide Genetic Test ($99 after your first month) analyzes key genetic variants—including GLP1R rs6923761, GIPR rs1800437, and MC4R rs17782313—that influence how your body responds to semaglutide and other peptide therapies. These insights help your PlexusDx provider predict whether you may need higher doses, respond exceptionally well at lower amounts, or benefit from combination therapies for optimal results.

Is there a maximum semaglutide dose for weight loss?

The standard maximum maintenance dose is 2.4 mg weekly, which is supported by large clinical trials. Some patients achieve their weight loss goals at 1.7 mg, while others need the full 2.4 mg. Your PlexusDx provider will work with you to identify the minimum effective dose that produces sustainable weight loss without unnecessary side effects.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves